Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 8

Results: 35

Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration.

Published in:

2008

By:

Chapuy, B.;
Koch, R.;
Radunski, U.;
Corsham, S.;
Cheong, N.;
Inagaki, N.;
Ban, N.;
Wenzel, D.;
Reinhardt, D.;
Zapf, A.;
Schweyer, S.;
Kosari, F.;
Klapper, W.;
Truemper, L.;
Wulf, G. G.

Publication type:

journal article

Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.

Published in:

2008

By:

Jundt, F.;
Acikgöz, Ö.;
Kwon, S.-H.;
Schwarzer, R.;
Anagnostopoulos, I.;
Wiesner, B.;
Mathas, S.;
Hummel, M.;
Stein, H.;
Reichardt, H. M.;
Dörken, B.;
Acikgöz, O;
Dörken, B

Publication type:

journal article

Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1542, doi. 10.1038/leu.2008.107

By:

Tschiedel, S.;
Gentilini, C.;
Lange, T.;
Wölfel, C.;
Lennerz, V.;
Stevanovic, S.;
Rammensee, H.-G.;
Huber, C.;
Cross, M.;
Niederwieser, D.

Publication type:

Article

Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1519, doi. 10.1038/leu.2008.118

By:

Modlich, U.;
Schambach, A.;
Brugman, M. H.;
Wicke, D. C.;
Knoess, S.;
Li, Z.;
Maetzig, T.;
Rudolph, C.;
Schlegelberger, B.;
Baum, C.

Publication type:

Article

Long-term molecular complete remission with IFN-α in Ph+ adult acute lymphoid leukemia patients.

Published in:

2008

By:

Piccaluga, P. P.;
Martinelli, G.;
Isidori, A.;
Malagola, M.;
Rondoni, M.;
Paolini, S.;
Amabile, M.;
Iacobucci, I.;
Baccarani, M.;
Visani, G.

Publication type:

Letter

New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G<sub>1</sub>/S-phase transition.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1557, doi. 10.1038/leu.2008.137

By:

Chaligné, R.;
Tonetti, C.;
Besancenot, R.;
Roy, L.;
Marty, C.;
Mossuz, P.;
Kiladjan, J.-J.;
Socié, G.;
Bordessoule, D.;
Le Bousse-Kerdilès, M. C.;
Vainchenker, W.;
Giraudier, S.

Publication type:

Article

Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1604, doi. 10.1038/leu.2008.111

By:

Stühmer, T.;
Zöllinger, A.;
Siegmund, D.;
Chatterjee, M.;
Grella, E.;
Knop, S.;
Kortüm, M.;
Unzicker, C.;
Jensen, M. R.;
Quadt, C.;
Chène, P.;
Schoepfer, J.;
Garcia-Echeverría, C.;
Einsele, H.;
Wajant, H.;
Bargou, R. C.

Publication type:

Article

Reply to Winter et al.

Published in:

2008

By:

Ostrovsky, O.;
Korostishevsky, M.;
Nagler, A.

Publication type:

Letter

Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1551, doi. 10.1038/leu.2008.115

By:

Higgs, J. R.;
Sadek, I.;
Neumann, P. E.;
Ing, V. W.;
Renault, N. K.;
Berman, J. N.;
Greer, W. L.

Publication type:

Article

NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?

Published in:

2008

By:

Bueno, C.;
Montes, R.;
Martín, L.;
Prat, I.;
Hernandez, M. C.;
Orfao, A.;
Menendez, P.;
Martín, L

Publication type:

Editorial

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1479, doi. 10.1038/leu.2008.127

By:

Hussein, M. A.;
Vrionis, F. D.;
Allison, R.;
Berenson, J.;
Berven, S.;
Erdem, E.;
Giralt, S.;
Jagannath, S.;
Kyle, R. A.;
LeGrand, S.;
Pflugmacher, R.;
Raie, N.;
Raikumar, S. V.;
Randall, L.;
Roodman, D.;
Siegel, D.;
Vescio, R.;
Zonder, J.;
Durie, B. G. M.

Publication type:

Article

Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1567, doi. 10.1038/leu.2008.128

By:

Gervais, C.;
Murati, A.;
Helias, C.;
Struski, S.;
Eischen, A.;
Lippert, E.;
Tigaud, I.;
Penther, D.;
Bastard, C.;
Mugneret, F.;
Poppe, B.;
Speleman, F.;
Talmant, P.;
Akker, J. VanDen;
Baranger, L.;
Barin, C.;
Luquet, I.;
Nadal, N.;
Nguyen-Khac, F.;
Maarek, O.

Publication type:

Article

Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma.

Published in:

2008

By:

Bard, J. Dien;
Gelebart, P.;
Anand, M.;
Amin, H. M.;
Lai, R.

Publication type:

journal article

Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia.

Published in:

2008

By:

Kuang, S.-Q.;
Tong, W.-G.;
Yang, H.;
Lin, W.;
Lee, M. K.;
Fang, Z. H.;
Wei, Y.;
Jelinek, J.;
Issa, J.-P.;
Garcia-Manero, G.

Publication type:

journal article

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more.

Published in:

2008

By:

Barlogie, B.;
van Rhee, F.;
Shaughnessy Jr., J. D.;
Anaissie, E.;
Crowley, J.;
Shaughnessy, J D Jr

Publication type:

Letter

Successful peripheral blood stem cell mobilization with granulocyte colony-stimulating factor in a patient with chronic myeloid leukemia achieving a complete cytogenetic remission with dasatinib after failing imatinib.

Published in:

2008

By:

Gabriel, I.;
Chaidos, A.;
Sorouri, J.;
Dannie, E.;
Davis, J.;
Goldman, J.;
Apperley, J.;
Marin, D.

Publication type:

Letter

Pathogenesis and treatment of renal failure in multiple myeloma.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1485, doi. 10.1038/leu.2008.131

By:

Dimopoulos, M. A.;
Kastritis, E.;
Rosinol, L.;
Bladé, J.;
Ludwig, H.

Publication type:

Article

Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1503, doi. 10.1038/leu.2008.141

By:

Zardo, G.;
Cimino, G.;
Nevi, C.

Publication type:

Article

MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.

Published in:

2008

By:

Curioni-Fontecedro, A.;
Knights, A. J.;
Tinguely, M.;
Nuber, N.;
Schneider, C.;
Thomson, C. W.;
von Boehmer, L.;
Bossart, W.;
Pahlich, S.;
Gehring, H.;
Moch, H.;
Renner, C.;
Knuth, A.;
Zippelius, A.

Publication type:

Letter

Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype.

Published in:

2008

By:

Haferlach, C.;
Dicker, F.;
Herholz, H.;
Schnittger, S.;
Kern, W.;
Haferlach, T.

Publication type:

journal article

BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias.

Published in:

2008

By:

Davidsson, J.;
Lilljebjörn, H.;
Panagopoulos, I.;
Fioretos, T.;
Johansson, B.

Publication type:

Letter

Evidence and expertise in the management of polycythemia vera and essential thrombocythemia.

Published in:

2008

By:

Finazzi, G.;
Barbui, T.

Publication type:

journal article

Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas originate from B-cell compartments with two different antigen-exposure histories.

Published in:

2008

By:

Parrens, M.;
Garchard, N.;
Petit, B.;
Marfak, A.;
Troadec, E.;
Bouabdhalla, K.;
Milpied, N.;
Merlio, J. P.;
de Mascarel, A.;
Laurent, C.;
Soubeyran, I.;
Coste, V.;
Labrousse, F.;
Cogné, M.;
Feuillard, J.

Publication type:

Letter

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement.

Published in:

2008

By:

Hussein, M A;
Vrionis, F D;
Allison, R;
Berenson, J;
Berven, S;
Erdem, E;
Giralt, S;
Jagannath, S;
Kyle, R A;
LeGrand, S;
Pflugmacher, R;
Raje, N;
Rajkumar, S V;
Randall, R L;
Roodman, D;
Siegel, D;
Vescio, R;
Zonder, J;
Durie, B G M

Publication type:

Correction Notice

Bortezomib therapy in myelofibrosis: a phase II clinical trial.

Published in:

2008

By:

Mesa, R. A.;
Verstovsek, S.;
Rivera, C.;
Pardanani, A.;
Hussein, K.;
Lasho, T.;
Wu, W.;
Tefferi, A.

Publication type:

clinical trial

Gefitinib potentiates myeloid cell differentiation by ATRA.

Published in:

2008

By:

Miranda, M. B.;
Duan, R.;
Thomas, S. M.;
Grandis, J. R.;
Redner, R. L.;
Jones, J. E.;
Johnson, D. E.

Publication type:

Letter

The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma.

Published in:

2008

By:

Hiwarkar, P.;
Arkenau, H.-T.;
Treleaven, J.;
Morgan, G.;
Potter, M.;
Ethell, M.

Publication type:

Letter

What do we mean by sensitivity when we talk about detecting minimal residual disease?

Published in:

2008

By:

Steinbach, D.;
Debatin, K.-M.

Publication type:

Letter

Low frequency of the glutathione-S-transferase T1-null genotype in patients with primary myelodysplastic syndrome and 5q deletion.

Published in:

2008

By:

Stravropoulou, C.;
Sambani, C.;
Rigana, H.;
Georgakakos, V. N.;
Voutsinas, G.;
Manola, K. N.;
Pantelias, G. E.;
Makropoulos, V.

Publication type:

Letter

ETV6 mutations and loss in AML-M0.

Published in:

2008

By:

Steinbach, D.;
Debatin, K.-M.

Publication type:

Letter

Reply to ‘Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukemia in patients from Northern Ireland’ by Winter et al.

Published in:

2008

By:

Ostrovsky, O.;
Korostishevsky, M.;
Nagler, A.

Publication type:

Letter

Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients from Northern Ireland.

Published in:

Leukemia (08876924), 2008, v. 22, n. 8, p. 1629, doi. 10.1038/leu.2008.36

By:

Winter, P. C.;
McMullin, M. F.;
Catherwood, M. A.

Publication type:

Article

Reply to Ostrovosky et al.

Published in:

2008

By:

Winter, P. C.;
McMullin, M. F.;
Catherwood, M. A.

Publication type:

Letter

A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease.

Published in:

2008

By:

Maslak, P. G.;
Dao, T.;
Gomez, M.;
Chanel, S.;
Packin, J.;
Korontzvit, T.;
Zakhaleva, V.;
Pinilla-Ibarz, J.;
Berman, E.;
Scheinberg, D. A.

Publication type:

Letter

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more.

Published in:

2008

By:

Barlogie, B.;
van Rhee, F.;
Shaughnessy Jr., J. D.;
Anaissie, E.;
Crowley, J.

Publication type:

Correction Notice